article · Kidney International Reports
Minimal Change Disease (MCD), accounts for 10–15% of primary nephrotic syndrome cases in adults. Limited studies have examined its clinical characteristics, treatment outcomes, and relapse factors in adults, particularly in low-income countries like Ethiopia. This study aimed to assess the treatment outcomes, and factors associated with relapse among adult patients with MCD at St. Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ekir.2026.105639
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
